Cited by 30Metabolism, Diabetes, and CancerPeroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

A New Leptin-Mediated Mechanism for Stimulating Fatty Acid Oxidation: A Pivotal Role for Sarcolemmal FAT/CD36

Open access
Momken, Iman, Chabowski, Adrian, Dirkx, Ellen, Nabben, Miranda, Jain, Swati S., McFarlan, Jay T., Glatz, Jan F.C., Luiken, Joost J.F.P. +1 more·2017·Biochemical Journal

Abstract

Leptin stimulates fatty acid oxidation in muscle and heart; but, the mechanism by which these tissues provide additional intracellular fatty acids for their oxidation remains unknown. We examined, in isolated muscle and cardiac myocytes, whether leptin, via AMP-activated protein kinase (AMPK) activation, stimulated fatty acid translocase (FAT/CD36)-mediated fatty acid uptake to enhance fatty acid oxidation. In both mouse skeletal muscle and rat cardiomyocytes, leptin increased fatty acid oxidation, an effect that was blocked when AMPK phosphorylation was inhibited by adenine 9-β-d-arabinofuranoside or Compound C. In wild-type mice, leptin induced the translocation of FAT/CD36 to the plasma membrane and increased fatty acid uptake into giant sarcolemmal vesicles and into cardiomyocytes. In muscles of FAT/CD36-KO mice, and in cardiomyocytes in which cell surface FAT/CD36 action was blocked by sulfo-N-succinimidyl oleate, the leptin-stimulated influx of fatty acids was inhibited; concomitantly, the normal leptin-stimulated increase in fatty acid oxidation was also prevented, despite the normal leptin-induced increase in AMPK phosphorylation. Conversely, in muscle of AMPK kinase-dead mice, leptin failed to induce the translocation of FAT/CD36, along with a failure to stimulate fatty acid uptake and oxidation. Similarly, when siRNA was used to reduce AMPK in HL-1 cardiomyocytes, leptin failed to induce the translocation of FAT/CD36. Our studies have revealed a novel mechanism of leptin-induced fatty acid oxidation in muscle tissue; namely, this process is dependent on the activation of AMPK to induce the translocation of FAT/CD36 to the plasma membrane, thereby stimulating fatty acid uptake. Without increasing this leptin-stimulated, FAT/CD36-dependent fatty acid uptake process, leptin-stimulated AMPK phosphorylation does not enhance fatty acid oxidation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bcj20160804

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Leptin-mediated activation of AMPK leads to phosphorylation and inhibition of ACC, reducing malonyl-CoA levels, which inhibits CPT1 and thereby reduces FA entry into mitochondria for β-oxidation.

    “The leptin-mediated activation of AMPK leads to the phosphorylation and inhibition of acetyl-CoA carboxylase (ACC), a rate-limiting enzyme in de novo fatty acid biosynthesis. This results in a reduction in the levels of malonyl-CoA, an inhibitor of CPT1, the enzyme responsible for shuttling FAs into mitochondria for β-oxidation”

    From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [99]

    The Results section reports that leptin increased AMPK and ACC phosphorylation, and the Figure 6 description links this pathway to increased fatty acid oxidation. Our copy does not establish the claimed reduction in malonyl-CoA. Moreover, the claim’s statement that this pathway reduces fatty-acid entry and oxidation conflicts with Figure 6’s description of increased fatty-acid uptake and oxidation; that reduction is not stated in the verbatim citing sentence. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Momken, I., Chabowski, A., Dirkx, E., Nabben, M., Jain, S. S., McFarlan, J. T., Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A.
Affiliations
  • Université d'Évry Val-d'Essonne (FR)
  • Medical University of Białystok (PL)
  • Maastricht University (NL)
  • University of Guelph (CA)
Venue
Biochemical Journal
Published
2016-12-22
Volume
474
Issue
1
Pages
149-162
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2556060577
Cited by
30
References
56
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 7 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 2
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Heart and Stroke Foundation of Canada
  • ZonMw
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (916.14.050)
  • Transnationale Universiteit Limburg
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
leptin, fatty acid oxidation, FAT/CD36, AMPK, fatty acid uptake, sarcolemma, skeletal muscle, cardiomyocytes, AMPK phosphorylation, adipokine signaling
MeSH terms
Animals, Cell Line, Fatty Acids, Oleic Acids, Oxidation-Reduction, Phosphorylation, Sarcolemma, Succinimides, Vidarabine, Mice, Knockout, Muscle, Skeletal, CD36 Antigens, Leptin, Protein Transport, Myocytes, Cardiac, Mice, Rats, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review